OVERLOOKED

Recalls › Medicines & devices

Class IIOngoing

Houston Rx LLC recalls 2 products

Recall date · record updated Oct 21, 2026 · Source: U.S. Food and Drug Administration (openFDA drug enforcement)

What to do

Check your product against the names and codes above. The FDA enforcement record lists the recall as voluntary: firm initiated; it does not state a consumer remedy, so follow the firm’s notice or the FDA link.

Company
Houston Rx LLC
Reason
Lack of assurance of sterility. Lack of process control
Hazard
FDA Class II: may cause temporary or medically reversible adverse health consequences (FDA definition).
Who’s affected
Nationwide in the USA.
Where
Nationwide
Official notice
www.accessdata.fda.gov/scripts/ires/index.cfm?Event=99990…

Products (2)

  1. Tirzepatide/Niacinamide 2mL vial (40 MG per Vial) Inj 20mg/2mg/mL, RX Only, Houston RX LLC, 15430 Vantage Parkway E STE 220, Houston, TX 77032.

    Codes/lots: Lot# TZN-080326-20/2-2, Beyond Use Date: 12/01/2026.Quantity: 64 vialsRecall no. D-0040-2027Class II

  2. Sermorelin, 1 mg/mL, 10 ml vial, Sterile injectable solution, RX Only, Houston RX LLC, 15430 Vantage Parkway E STE 220, Houston, TX 77032.

    Codes/lots: Lot# SER-081726-1-10, Beyond Use Date: 10/01/2026.Quantity: 7 vialsRecall no. D-0041-2027Class II

Update history

  1. First listed on OVERLOOKED from the official record.

When the agency expands or changes this recall, we update this page and log the change here.

Proof: raw official record (JSON) · fetched from FDA API

More Medicines & devices recalls